QQ客服 官方微博 反馈留言

	A phase II study of Chinese patients (pts) treated with nab-paclitaxel (nab-P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC)
	Shen L., Yu X., Hao J., Wang L., Pan H., Han G., Xu J.-M., Zhang Y., Yang S., Chen J., Ying J., Dai G., Li M., Begic D., Lu B.D., Xu R.
刊名	Journal of Clinical Oncology
	2016
卷号	34
ISSN号	0732-183X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3627408
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Shen L., Yu X., Hao J., Wang L., Pan H., Han G., Xu J.-M., Zhang Y., Yang S., Chen J., Ying J., Dai G., Li M., Begic D., Lu B.D., Xu R.. A phase II study of Chinese patients (pts) treated with nab-paclitaxel (nab-P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC)[J]. Journal of Clinical Oncology,2016,34.
APA	Shen L., Yu X., Hao J., Wang L., Pan H., Han G., Xu J.-M., Zhang Y., Yang S., Chen J., Ying J., Dai G., Li M., Begic D., Lu B.D., Xu R..(2016).A phase II study of Chinese patients (pts) treated with nab-paclitaxel (nab-P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC).Journal of Clinical Oncology,34.
MLA	Shen L., Yu X., Hao J., Wang L., Pan H., Han G., Xu J.-M., Zhang Y., Yang S., Chen J., Ying J., Dai G., Li M., Begic D., Lu B.D., Xu R.."A phase II study of Chinese patients (pts) treated with nab-paclitaxel (nab-P) plus gemcitabine (Gem) for metastatic pancreatic cancer (MPC)".Journal of Clinical Oncology 34(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。